UROCIT-K 15 MEQ Extended Release Oral Tablet
RxNorm 898517
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 898517 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: UROCIT-K 15 MEQ Extended Release Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
K+ citrate 15 MEQ Extended Release Oral Tablet [Urocit-K]
(Atom ID: 6356921)
SYPrescribable
Synonym (SY):
Pot citrate 15 MEQ Extended Release Oral Tablet [Urocit-K]
(Atom ID: 6357244)
SBDPrescribable
Semantic Branded Drug (SBD):
Potassium citrate 15 MEQ Extended Release Oral Tablet [Urocit-K]
(Atom ID: 6351675)
PSNPrescribable
Prescribable Name (PSN):
UROCIT-K 15 MEQ Extended Release Oral Tablet
(Atom ID: 6361857)
SYPrescribable
Synonym (SY):
Urocit-K 15 MEQ Extended Release Oral Tablet
(Atom ID: 6356261)
SYPrescribable
Synonym (SY):
Urocit-K 1620 mg Extended Release Oral Tablet
(Atom ID: 6358232)
Patient Education
Potassium
Potassium is essential for the proper functioning of the heart, kidneys, muscles, nerves, and digestive system. Usually the food you eat supplies all of the potassium you need. However, certain diseases (e.g., kidney disease and gastrointestinal disease with vomiting and diarrhea) and drugs, especially diuretics ('water pills'), remove potassium from the body. Potassium supplements are taken to replace potassium losses and prevent potassium deficiency. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
[Learn More]
* Please review the disclaimer below.